- Full Year 2023 Ucb SA Earnings Call TranscriptFeb 28, 2024€105 (+8.09%)Earnings
- Half Year 2023 Ucb SA Earnings Call TranscriptJul 27, 2023€80.86 (+0.12%)Earnings
- Ucb SA Update on BKZ US Review and Rystiggo US Approval Call TranscriptJun 27, 2023
- Full Year 2022 Ucb SA Earnings Call TranscriptFeb 22, 2023€80.98 (+2.38%)Earnings
- Full Year 2021 UCB SA Earnings Call TranscriptFeb 24, 2022€91.9 (+4.08%)Earnings
- UCB SA to Acquire Zogenix Inc Capital Markets Call TranscriptJan 19, 2022
- Half Year 2021 UCB SA Earnings Call TranscriptJul 29, 2021€91.6 (+1.42%)Earnings
- Full Year 2020 UCB SA Earnings Call TranscriptFeb 25, 2021€86 (+5.76%)Earnings
- UCB SA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Ucb SA Analysts and Investors Conference Call TranscriptNov 12, 2020
- Q2 2020 Ucb SA Earnings Call TranscriptJul 27, 2020€110.75 (+0.73%)Earnings
- Full Year 2019 Ucb SA Earnings Call TranscriptFeb 20, 2020€92.28 (+3.11%)Earnings
- Ucb SA to Acquire Ra Pharmaceuticals Inc Call TranscriptOct 10, 2019
- Q2 2019 Ucb SA Earnings Call TranscriptJul 25, 2019€71.34 (-5.03%)Earnings
- Q4 2018 Ucb SA Earnings Call TranscriptFeb 28, 2019€73.68 (-4.29%)Earnings
Full Year 2020 UCB SA Earnings Call Transcript
Ladies and gentlemen, welcome to today's investor call (inaudible) on Full Year 2020 Financial Results Conference call and webcast. (Operator Instructions) Please note that this conference call will be recorded and that a replay of the video webcast will be available later today.
I am now pleased to hand over to Mrs. Antje Witte, Head of Investor Relations, who will be the moderator of this conference. Mrs. Witte, the floor is yours.
Thank you very much. Hello. Hope you're doing well, safe and sound. Good day to you. Welcome to this call.
On the next slide, you will find our disclaimer and safe harbor statement under which this call and the following Q&A session, as usual, is to be seen, and we kindly request that you read this carefully.
On the next slide, you find the panel of today's presentation. And very soon, I will hand over to Jean-Christophe Tellier, our CEO.
We then have Emmanuel Caeymaex, our Vice President -- Executive Vice President, sorry, for Immunology Solutions, who
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)